AzTrials
AzTrials

Cerebral PalsyNCT06203366

Effect of Vojta Therapy on Upper Extremity Function of Children With Cerebral Palsy

A study testing Vojta therapy in people with Cerebral Palsy and Upper Extremity, run by Mahidol University at 1 site in Thailand.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this pilot study is to study the effect of Vojta therpy on upper extremity function in children with cerebral palsy. The main questions are: to study the effect of Vojta therapy on upper extremity function in children with cerebral palsy in terms of range of motion and function to study the effect of Vojta… Read more about this study

Who is it for?
Ages 7 to 12 years
Conditions the study is for
Cerebral Palsy, Upper Extremity, Vojta Therapy
What is being tested?
Vojta therapy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteThailand
Study dates
15 Nov 2023to 30 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • spastic diplegia (MACS II-III)
  • can pick box and block test at least 1 block
  • has good trunk stability while sitting
  • can follow command
  • participant and guardian consent to the study

Who cannot join

  • no Vojta therapy in last 2 months
  • no history of anti-spastic injection in last 6 months
  • do not receive prednisolone nor adrenocorticotropic hormone (ACTH)
  • cannot control seizure
  • got the specific disease such as osteogenesis imperecta, cardiac disease
  • Participant and guardians do not consent to the study.

Trial locations and contacts

1 site in 1 country.

Thailand1 site
  • Srisangwan School Foundation for the Welfare of the Crippled under Royal Patronage of Her Royal Highness the Princess Mother

    Nonthaburi, 11120

Other trials in Thailand

About this study

Official title: Effect of Vojta Therapy on Upper Extremity Function of Children With Cerebral

The goal of this pilot study is to study the effect of Vojta therpy on upper extremity function in children with cerebral palsy. The main questions are:

  • to study the effect of Vojta therapy on upper extremity function in children with cerebral palsy in terms of range of motion and function
  • to study the effect of Vojta therapy on upper extremity function in children with cerebral palsy in terms of motion analysis while perform function
Read the detailed description

Vojta therapy is an old treatment method which was discovered by Professor Vaclav Vojta, a neurologist and pediatrician. It has been used to treat children with impair motor function in Thailand since 2011. Vojta therapy encourage the movement of children via positioning and stimulate the specified zone.

Being tested
Vojta therapy
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vojta therapyProcedure or surgery

    Vojta therapy is an old treatment method which was discovered by Professor Vaclav Vojta, a neurologist and pediatrician. It has been used to treat children with impair motor function in Thailand since 2011. Vojta therapy encourage the movement of children via positioning and stimulate the specified zone.

Study groups in NCT06203366
Study groupRoleWhat they receive
Experimental groupExperimental* got the Vojta treatment 30 minutes/session, 3 times/week for 8 weeks * got the ADL and kinetic activities training 30 minutes, 3 times/week for 8 weeks
Receives: Procedure: Vojta therapy
control groupNo intervention- got the ADL and kinetic activities training 30 minutes, 3 times/week for 8 weeks

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Box and block test

    the children have to pick the 1"*1" cube blocks from one side of the box to the other side in 1 minute

    Measured: Baseline (before) and within 1 week after the final treatment

Secondary outcomes (4)
  1. active range of motion of upper extremity

    the children was asked to active move their shoulder, elbow and wrist for measurement

    Measured: Baseline (before) and within 1 week after the final treatment

  2. Nine hole peg test

    the children have to pick 9 pegs from the container to insert into the providing holes and record the time

    Measured: Baseline (before) and within 1 week after the final treatment

  3. 3D motion analysis of upper extremity

    the markers were attached at back, sternum, both shoulders, elbows and wrists. Then, children were to forward rech the object on the table. The camera and mrakers will record and analyz the motion of both upper extremities. This measurement will be done only in children who was treated with Vojta therapy group only. This measurement will report in distance of maximum reaching, velocity and angle velocitym of shoulder, elbow, wrist with forearm pronation/supination. The other parameters are movement duration, peak velocity, time to peak velocity and trajectory straigthness.

    Measured: Baseline (before) and within 1 week after the final treatment

  4. Video recording

    The camera video will record the distance of maximum reaching in forward reaching and lateral reaching during the 3D kinematics evaluation in the gait lab of both upper extremities movement. This outcome was done in only the intervention group who received Vojta treatment.

    Measured: Baseline (before) and within 1 week after the final treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2024
  2. Study start15 Nov 2023
  3. Primary completion30 Aug 2024
  4. Study completion30 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06203366
Sponsor's protocol ID
MURA2023/780
Status last verified
Sep 2024
First submitted
30 Nov 2023
Last updated
24 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: For the study protocol and informed consent, they will be shared to all of the researchers. for the study protocol, SAP, ICF,CSR and analytic code, they will he shared to Chananchida Widchayasart and Parit Wongphaet after finishing data collection.

Publications

  • Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, Jacobsson B, Damiano D; Executive Committee for the Definition of Cerebral Palsy. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol. 2005 Aug;47(8):571-6. doi: 10.1017/s001216220500112x.

    PubMed 16108461
  • Sadowska M, Sarecka-Hujar B, Kopyta I. Cerebral Palsy: Current Opinions on Definition, Epidemiology, Risk Factors, Classification and Treatment Options. Neuropsychiatr Dis Treat. 2020 Jun 12;16:1505-1518. doi: 10.2147/NDT.S235165. eCollection 2020.

    PubMed 32606703
  • Prusmetikul S, Vongpipatana S, Woratanarat P, Tuntiyatorn P, Tamonsawatruk T. Correlation of range of motion and functional performance of upper extremities in children with cerebral palsy. J Med Assoc Thai 2018;101;Suppl.3

  • Peeters LHC, de Groot IJM, Geurts ACH. Trunk involvement in performing upper extremity activities while seated in neurological patients with a flaccid trunk - A review. Gait Posture. 2018 May;62:46-55. doi: 10.1016/j.gaitpost.2018.02.028. Epub 2018 Mar 6.

    PubMed 29524797
  • Kara OK, Yardimci BN, Sahin S, Orhan C, Livanelioglu A, Soylu AR. Combined Effects of Mirror Therapy and Exercises on the Upper Extremities in Children with Unilateral Cerebral Palsy: A Randomized Controlled Trial. Dev Neurorehabil. 2020 May;23(4):253-264. doi: 10.1080/17518423.2019.1662853. Epub 2019 Sep 13.

    PubMed 31514564
  • Sirindhorn National Medical Rehabilitation Centre. Vojta therapy in childhood. Bangkok: Department of Medical Services, Ministry of Public Health; October 2556.

  • Sung YH, Ha SY. The Vojta approach changes thicknesses of abdominal muscles and gait in children with spastic cerebral palsy: A randomized controlled trial, pilot study. Technol Health Care. 2020;28(3):293-301. doi: 10.3233/THC-191726.

    PubMed 31658070
  • Khiewcham P., Vongpipatana S., Wongphaet P., Thipsook K. Effect of Vojta Therapy on Gait of Children with Cerebral Palsy. J Thai Rehabil Med 2016; 26(3): 91-97

  • Lim H, Kim T. Effects of vojta therapy on gait of children with spastic diplegia. J Phys Ther Sci. 2013 Dec;25(12):1605-8. doi: 10.1589/jpts.25.1605. Epub 2014 Jan 8.

    PubMed 24409030
  • Matic-Tec.de, S.R.| Therapie, Vojta. Available at: https://www.vojta.com/de/vojta-prinzip/vojtatherapie (Accessed: February 15, 2023).

Questions about this trial

What is this clinical trial studying?

A study testing Vojta therapy in people with Cerebral Palsy and Upper Extremity, run by Mahidol University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Box and block test (time frame: Baseline (before) and within 1 week after the final treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06203366, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in